What is the projected market valuation for the US general surgical-devices market in 2035?

The projected market valuation for the US general surgical-devices market in 2035 is $13.5 Billion. Read More

What was the market valuation for the US general surgical-devices market in 2024?

The market valuation for the US general surgical-devices market in 2024 was $5.5 Billion. Read More

What is the expected CAGR for the US general surgical-devices market during the forecast period 2025 - 2035?

The expected CAGR for the US general surgical-devices market during the forecast period 2025 - 2035 is 8.51%. Read More

Which segment of the US general surgical-devices market had the highest valuation in 2024?

In 2024, the segment of the US general surgical-devices market with the highest valuation was General Surgery, at $2.5 Billion. Read More

What are the projected valuations for Electrosurgical Devices by 2035?

The projected valuation for Electrosurgical Devices by 2035 is $3.95 Billion. Read More

Which key players are leading the US general surgical-devices market?

Key players leading the US general surgical-devices market include Medtronic, Johnson & Johnson, and Stryker. Read More

What is the projected valuation for Minimally Invasive Surgery by 2035?

The projected valuation for Minimally Invasive Surgery by 2035 is $8.3 Billion. Read More

How much is the market for Sutures and Staplers expected to grow by 2035?

The market for Sutures and Staplers is expected to grow to $4.0 Billion by 2035. Read More

What is the expected valuation for Ambulatory Surgical Centers in 2035?

The expected valuation for Ambulatory Surgical Centers in 2035 is $4.05 Billion. Read More

Which application segment is projected to have the highest growth by 2035?

The application segment projected to have the highest growth by 2035 is General Surgery, with a valuation of $6.0 Billion. Read More

US General Surgical Devices Market

ID: MRFR/MED/16419-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US General Surgical Devices Market Research Report: By Product Type (Electrosurgical Devices, Handheld Surgical Instruments, Laparoscopic Devices, Sutures and Staplers), By Application (Cardiothoracic Surgery, Orthopedic Surgery, General Surgery, Obstetrics and Gynecology), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Procedure Type (Open Surgery, Minimally Invasive Surgery) - Growth & Industry Forecast 2025 To 2035

US General Surgical Devices Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Type (USD Billion)
  1. 4.1.1 Electrosurgical Devices
  2. 4.1.2 Handheld Surgical Instruments
  3. 4.1.3 Laparoscopic Devices
  4. 4.1.4 Sutures and Staplers
2. 4.2 Pharmaceutical, BY Application (USD Billion)
  1. 4.2.1 Cardiothoracic Surgery
  2. 4.2.2 Orthopedic Surgery
  3. 4.2.3 General Surgery
  4. 4.2.4 Obstetrics and Gynecology
3. 4.3 Pharmaceutical, BY End Use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Ambulatory Surgical Centers
  3. 4.3.3 Specialty Clinics
4. 4.4 Pharmaceutical, BY Procedure Type (USD Billion)
  1. 4.4.1 Open Surgery
  2. 4.4.2 Minimally Invasive Surgery
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Stryker (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boston Scientific (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 B. Braun Melsungen AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Smith & Nephew (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Zimmer Biomet (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Conmed Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Hernia Solutions (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY PROCEDURE TYPE
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
16. 6.16 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Billion)
18. 6.18 PHARMACEUTICAL, BY PROCEDURE TYPE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Billion, 2025-2035)

Electrosurgical Devices
Handheld Surgical Instruments
Laparoscopic Devices
Sutures and Staplers

Pharmaceutical By Application (USD Billion, 2025-2035)

Cardiothoracic Surgery
Orthopedic Surgery
General Surgery
Obstetrics and Gynecology

Pharmaceutical By End Use (USD Billion, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Pharmaceutical By Procedure Type (USD Billion, 2025-2035)

Open Surgery
Minimally Invasive Surgery

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”